RO 7020531Alternative Names: RO7020531
Latest Information Update: 11 Nov 2016
At a glance
- Originator Roche
- Class Antivirals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Hepatitis B
Most Recent Events
- 03 Nov 2016 Preclinical trials in Hepatitis B in Switzerland (PO) before November 2016
- 03 Nov 2016 Roche plans a phase I trial for chronic Hepatitis B in New Zealand (PO) (NCT02956850)